Sofía Tejada
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
-
- Nosocomial Infections in ICU
Papers in
-
- COVID-19 Clinical Research Studies 8
- Antifungal resistance and susceptibility 4
-
- Nosocomial Infections in ICU 6
- Co-authors
- Jordi Rello (26 shared papers)Yolanda Peña-López (4 shared papers)Oriol Manuel (3 shared papers)Ana Lucía Rincón Villagra (1 shared paper)Javier Maynar (1 shared paper)Sara Cabañes (1 shared paper)Helena Barrasa (1 shared paper)Alejandro Herrero San Martín (1 shared paper)
In The Last Decade
Sofía Tejada
39 papers receiving 806 citations
Sofía Tejada's Hit Papers
Peers
Comparison fields: 5 of 85
- Infectious Diseases 394
- Critical Care and Intensive Care Medicine 60
- Applied Microbiology and Biotechnology 17
- Epidemiology 161
- Emergency Medical Services 22
Countries citing papers authored by Sofía Tejada
This map shows the geographic impact of Sofía Tejada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Tejada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Tejada more than expected).
Fields of papers citing papers by Sofía Tejada
This network shows the impact of papers produced by Sofía Tejada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Tejada. The network helps show where Sofía Tejada may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofía Tejada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 175 | |
| 2 | Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM Hit paper breakdown → | 2024 | 111 |
| 3 | 2022 | 79 | |
| 4 | 2020 | 63 | |
| 5 | 2023 | 36 | |
| 6 | 2020 | 33 | |
| 7 | 2022 | 31 | |
| 8 | 2023 | 26 | |
| 9 | 2020 | 25 | |
| 10 | 2021 | 25 | |
| 11 | 2022 | 23 | |
| 12 | 2022 | 22 | |
| 13 | 2022 | 22 | |
| 14 | 2021 | 20 | |
| 15 | 2019 | 16 | |
| 16 | 2022 | 13 | |
| 17 | 2020 | 10 | |
| 18 | 2021 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2022 | 7 |
About Sofía Tejada
Sofía Tejada is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Epidemiology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 837 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Nosocomial Infections in ICU (6 papers), Antifungal resistance and susceptibility (4 papers), Clinical practice guidelines implementation (4 papers), Biosensors and Analytical Detection (4 papers), Sepsis Diagnosis and Treatment (3 papers), Pneumonia and Respiratory Infections (3 papers) and Influenza Virus Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (394 citations), Critical Care and Intensive Care Medicine (60 citations), Applied Microbiology and Biotechnology (17 citations), Epidemiology (161 citations) and Emergency Medical Services (22 citations). Sofía Tejada has collaborated with scholars based in Spain, France and Italy. Frequent co-authors include Jordi Rello, Yolanda Peña-López, Oriol Manuel, Ana Lucía Rincón Villagra, Javier Maynar, Sara Cabañes, Helena Barrasa, Alejandro Herrero San Martín, GRANT W. WATERER and Laura Campogiani. Their work appears in journals such as Anaesthesia Critical Care & Pain Medicine, European Journal of Internal Medicine, European Journal of Clinical Microbiology & Infectious Diseases, Biosensors and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.